News
Previously granted Emergency Use Authorization, Nuvaxovid is now available for individuals over 12 years of age.
The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine, but with unusual ...
"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...
The FDA has approved the Novavax COVID-19 vaccine, called Nuvaxovid, mainly for adults 65 or older, but people ages 12 to 64 with medical conditions that increase their risk of serious illness from ...
In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...
Novavax Inc. jumped as US regulators fully approved its Covid vaccine, easing investors’ concerns after the clearance was ...
The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...
(Reuters) -Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 ...
In the Phase 2 study of patients with chronic kidney disease, the highest dose of the drug lowered by 86% the levels of ...
WASHINGTON — Robert F. Kennedy Jr. clinched the political support needed to become the nation’s top health official by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results